Showing results (201-210 of 752) with videos related to
Sort By:
Pageof 76
Neuro-Oncology|April 25, 2020
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatmentRaymond Y Huang, Robert J Young, Benjamin M Ellingson, et al.Neuro-Oncology|April 12, 2008
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adultsSantosh Kesari, David Schiff, John W Henson, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Phase I study of GRN1005 in recurrent malignant gliomaJan Drappatz, Andrew Brenner, Eric T Wong, et al.World Neurosurgery|November 29, 2016
Geographically Remote Cerebral Venous Sinus Thrombosis in Patients with Intracranial TumorsDaniel M S Raper, Alicia M Zukas, David Schiff, et al.Journal of Neuro-Oncology|November 4, 2006
Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomasNader Pouratian, Jaime Gasco, Jonathan H Sherman, et al.Frontiers in Radiology|December 28, 2023
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integrationFrancesco Sanvito, Timothy J Kaufmann, Timothy F Cloughesy, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2024
Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastomaNathan McDannold, Patrick Y Wen, David A Reardon, et al.Neuro-Oncology|March 19, 2016
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD)Jennifer L Helfer, Patrick Y Wen, Jaishri Blakeley, et al.Neuro-Oncology|October 15, 2014
Pros and cons of current brain tumor imagingBenjamin M Ellingson, Patrick Y Wen, Martin J van den Bent, et al.Pageof 76